Methods of treating a subject with benign prostate hyperplasia
US8815309B2 · kind B2 · utility
1Cited by
38References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 7, 2011 |
| Grant date | Aug 26, 2014 |
| Priority date | — |
| Expiry date | Jan 7, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2018/2005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention generally relates to methods of treating a male subject with a prostate condition, for example, benign prostate hyperplasia (BPH). In certain embodiments, the invention provides methods of treating a male subject with a prostate condition, which include administering a MetAP2 inhibitor at a dose that does not substantially modulate angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.